Duoforte 27 GEL
Natural health product licensed in Canada
- Licence holder
- Haleon US Holdings LLC
- NPN or DIN-HM
- 01939645
- Status
- Inactive licence
- Licence date
- 22 December 2009
- Revision date
- 22 February 2017
- Form
- Solution semblabe au collodion.
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide salicylique Source : Synthétique | 27 % |
Non-medicinal ingredients
Hydroxypropylcellulose, Flexible collodion, Alcool, Ethyl lactate, Méthacrylate de poly (méthyle), Polybutylene
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 3 years | 1 Goutte(s) | 24 hours |
Uses authorised in Canada
Text supplied in English because no French text is available.
For the removal of common warts.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 01939645
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging